Le Lézard
Classified in: Health
Subjects: NPT, STP, AVO

New York City Passes Sweeping Package of Bills to Further Reduce Tobacco Use


WASHINGTON, Aug. 9, 2017 /PRNewswire-USNewswire/ -- Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

Today New York City has again taken bold action to further reduce tobacco use, the No. 1 cause of preventable death in the United States. The New York City Council approved a sweeping package of legislation introduced in April by Mayor Bill de Blasio and members of the Council that will increase the price and reduce the availability of cigarettes and other tobacco products.

These measures build on the enormous progress New York City has made in reducing tobacco use. They will prevent children from starting to use tobacco, encourage current tobacco users to quit and save lives. Thanks to these strong and innovative laws, New York City will again be a national leader in fighting tobacco use.

We applaud Mayor de Blasio, Health Commissioner Dr. Mary T. Bassett, City Council Speaker Melissa Mark-Viverito, Council Members Corey Johnson, Brad Lander, Fernando Cabrera, James Vacca and Ritchie Torres, and other public health advocates for championing this legislation and providing strong leadership in the fight against tobacco.

The bills approved today will:

These measures will save lives and improve the health of New York City residents for generations to come.

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

at 02:05
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and...

at 01:18
. Hansa Biopharma, "Hansa" (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American...

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by...

at 00:01
Celltrion USA announced today...

at 00:01
SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) ? defined as people living with ulcerative colitis or Crohn's...



News published on and distributed by: